Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Kraig Biocraft Laboratories's Capital Expenditure for the three months ended in Dec. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-1.19 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Kraig Biocraft Laboratories Capex-to-Operating-Income Historical Data

The historical data trend for Kraig Biocraft Laboratories's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kraig Biocraft Laboratories Capex-to-Operating-Income Chart

Kraig Biocraft Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capex-to-Operating-Income

Get a 7-Day Free Trial

Kraig Biocraft Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Kraig Biocraft Laboratories's Capex-to-Operating-Income

For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kraig Biocraft Laboratories's Capex-to-Operating-Income Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Kraig Biocraft Laboratories's Capex-to-Operating-Income falls into.

Kraig Biocraft Laboratories Capex-to-Operating-Income Calculation

Kraig Biocraft Laboratories's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-0.006)	/	-2.615
	=	N/A

Kraig Biocraft Laboratories's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	-1.188
	=	N/A

Kraig Biocraft Laboratories (OTCPK:KBLB) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Kraig Biocraft Laboratories Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104

Website

https://www.kraiglabs.com

Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra. It generates the majority of its revenues from its business across the United States.

Executives

Jonathan Richard Rice	officer: COO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson	director, 10 percent owner, officer: CEO, CFO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401